Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy

Overview of attention for article published in Frontiers in Genetics, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 13,025 followers.

Neoepitope load, t cell signatures and pd-l2 as combined biomarker strategy for response to checkpoint inhibition immunother... - Borch A et al. - https://t.co/9dnajPiG4E #microbiome

10 Apr 2023

Reply Repost Favourite

RT @FrontGenetics: New Research: Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inh…

23 Mar 2023

Reply Repost Favourite

New Research: Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy: Immune checkpoint inhibition for the treatment of cancer has provided a breakthrough in oncology, and… https://t.

23 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.